CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
37.22
-0.37 (-0.98%)
At close: May 13, 2025, 4:00 PM
37.34
+0.12 (0.32%)
Pre-market: May 14, 2025, 7:11 AM EDT
CRISPR Therapeutics AG Employees
CRISPR Therapeutics AG had 393 employees as of December 31, 2024. The number of employees decreased by 14 or -3.44% compared to the previous year.
Employees
393
Change (1Y)
-14
Growth (1Y)
-3.44%
Revenue / Employee
$95,865
Profits / Employee
-$981,316
Market Cap
3.21B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
CRSP News
- 5 days ago - Crispr Therapeutics: Complex Casgevy Launch, But Broader Gene-Editing Potential Still Shines - Seeking Alpha
- 5 days ago - CRISPR Therapeutics Struggles Under Slow Adoption And Regulatory Uncertainty (Downgrade) - Seeking Alpha
- 6 days ago - Crispr Therapeutics Q1 Earnings Analysis: Ignore The Gloom, Stay The Course - Seeking Alpha
- 6 days ago - CRISPR Therapeutics' Data Shows Promise, But RFK Jr. Appointee Could Be Negative: Analyst - Benzinga
- 6 days ago - These Analysts Slash Their Forecasts On CRISPR Therapeutics Following Q1 Results - Benzinga
- 7 days ago - CRISPR Therapeutics Provides First Quarter 2025 Financial Results and Announces Positive Top-Line Data from Phase 1 Clinical Trial of CTX310™ Targeting ANGPTL3 - GlobeNewsWire
- 9 days ago - CRISPR Therapeutics And Intellia Therapeutics: Balancing Market Uncertainty Against Pipeline Catalysts - Seeking Alpha
- 5 weeks ago - CRISPR Therapeutics AG (CRSP) Annual Needham Virtual Healthcare Conference (Transcript) - Seeking Alpha